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MAPKAPK-2 Signaling Is Critical for Cutaneous
Wound Healing
Thusanth Thuraisingam1,4, Yong Zhong Xu2, Kalyn Eadie2, Mitra Heravi1, Marie-Cristine Guiot3,
Rony Greemberg4, Matthias Gaestel5 and Danuta Radzioch1,2
Cutaneous wound healing is a complex process, which is heavily dependent on successful inflammatory action.
Mitogen-activated protein kinase (MAPK)-activated protein kinase-2 (MAPKAPK-2 or MK2), a major substrate of
p38 MAPK, has been shown to be a major player in multiple inflammatory diseases, but its role in cutaneous
wound healing has not yet been explored. In this study, by comparing excisional wounds made on the backs of
MK2 knockout (KO) and MK2 wild-type (WT) mice, we found that the kinetics of wound healing are significantly
affected by the absence of MK2 (P¼ 0.010 to Po0.001). Histological examination showed a higher level of
acanthosis of the migrating wound keratinocyte layer as well as a higher level of collagen deposition in the
granulation tissue of the wounds from MK2 WT mice compared with those from MK2 KO mice. Interestingly,
although MK2 did not influence macrophage and neutrophil infiltration of the wounds, the expression of many
cytokines and chemokines was significantly affected at different days post wounding. Furthermore, the delayed
healing rate of wounds in MK2 KO mice can be significantly improved by passive transfer of macrophages with
intact MK2. Overall, these results show a critical role for MK2 gene expression in macrophages participating in
the process of cutaneous wound healing.
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INTRODUCTION
Mitogen-activated protein kinase (MAPK)-activated protein
kinase-2 (MAPKAPK2 or MK2) is a serine/threonine kinase of
the p38 MAPK pathway. p38 MAPK activation is critical in
the response to cellular stress from stimuli such as UV
radiation or IL-1b (Saklatvala, 2004). In resting cells, p38
MAPK and MK2 are physically bound together in the nucleus
(Ben-Levy et al., 1998). Cellular stress causes the phos-
phorylation of p38 MAPK by an upstream kinase such as
MKK3 (Kim et al., 2007). The activated p38 MAPK then
phosphorylates MK2 at residues Thr-222, Ser-272, and/or
Thr-334 (Engel et al., 1998). The activated MK2 and p38, still
physically bound together, translocate to the cytoplasm,
where they phosphorylate their respective target proteins
(Ben-Levy et al., 1998).
MK2 phosphorylation of its target proteins has been shown
to play a critical role in cell cycle regulation, actin
remodeling, cell development and migration, and cytokine
production (Kotlyarov et al., 1999; Kayyali et al., 2002;
Kobayashi et al., 2006; Xiao et al., 2006; Reinhardt et al.,
2007; Thuraisingam et al., 2007). A recent study with
cultured keratinocytes has shown that depleting MK2 through
the use of small interfering RNA technology severely impairs
the ability of the keratinocytes to produce several cytokines,
including tumor necrosis factor (TNF) and IL-8 (Johansen
et al., 2006). MK2 is also necessary for myofibroblast
formation in vivo, as shown using a model of pulmonary
fibrosis (Liu et al., 2007).
The ability of MK2 to regulate inflammation has been
extensively studied. Several studies have shown the impor-
tance of MK2 in the regulation of both intracellular and
secretory proteins (Kotlyarov et al., 1999; Neininger et al.,
2002; Gaestel, 2006; Kobayashi et al., 2006). Many mRNAs,
including those of inflammatory cytokines such as TNF and
protooncogenes such as c-myc, contain AU-rich elements in
their 30 untranslated regions (Chen and Shyu, 1995). Several
AU-rich element-binding proteins (ABPs), can regulate the
stability, transport, and/or translational efficiency of mRNA
by binding to their 30 region (Dixon et al., 2003; Rigby et al.,
2005). Besides p38, MK2 is the only other known kinase
that has been shown to directly phosphorylate these ABPs
(Gaestel, 2006). Recently, we have shown that the induction
of several cytokines and chemokines in macrophages, in
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response to Toll-like receptor stimulation, is dependent on
the p38/MK2 signaling pathway (Thuraisingam et al., 2007).
One of the major biological processes that are heavily
dependent on the inflammatory process is wound healing
subsequent to an injury. Macrophages are known to secrete
essential growth factors and inflammatory mediators that
coordinate important processes such as collagen deposition,
wound contraction, and angiogenesis during wound healing
(Danon et al., 1989; Ashcroft et al., 2000; Low et al., 2001;
Peters et al., 2005; Fang et al., 2007). To investigate the
possible role of MK2 in this process, cutaneous wounds were
made on MK2 knockout (KO) mice and their rate of healing
was compared with that of their wild-type (WT) counterparts.
In the current study, we characterize the kinetics of healing,
collagen deposition at the wound site, the induction of
cytokines and chemokines, and the recruitment of inflam-
matory cells to the wounds of the mice lacking MK2 and their
WT counterparts. To provide better support to our conclu-
sion, we also assess the effect of the passive transfer of
macrophages containing intact MK2 into MK2 KO mice on
wound healing. Overall, our study provides strong data
showing the importance of MK2 in cutaneous wound healing,
and links it directly to the inflammatory process.
RESULTS
MK2-deficient mice are severely delayed in their rate of wound
healing
To investigate the role of MK2 in wound healing, 6-mm
circular wounds were made on the shaved backs of MK2 KO
mice and their MK2 WT counterparts. The wounds were
monitored daily. Immediately post wounding, the wound
sizes were very similar between the mouse strains (Figure 1a
and b). As early as day 1 post wounding, MK2 WT mice had a
significantly smaller wound area (P¼0.009). This difference
remained statistically significant until day 12 post wounding
(Po0.001 to P¼ 0.010, Figure 1b), when wounds of MK2
WT, but not of MK2 KO, mice were fully healed. Beyond
day 12, MK2 KO mice wound areas seemed to gradually
approximate those of WT mice, and by day 14, wounds from
both strains of mice were healed. Thus, compared with that
of the MK2 WT mice, there seems to be a significant delay
in the kinetics of wound healing in the MK2 KO mice,
suggesting altered mechanisms of healing in these mice.
To confirm the difference in the kinetics of wound healing
between WT and MK2 KO mice, wounds were also analyzed
histologically. At day 4 post wounding, wounds were excised
with a clear margin, bisected before paraffin embedding, and
further processed for histological studies. Unwounded skin
from both MK2 WT and MK2 KO mice showed similarly
normal histoarchitecture, with no epidermal acanthosis,
similar numbers of adnexal structures, paucity of inflamma-
tory cell infiltrate, and subcutaneous fat layer (data not
shown). In contrast, in wounded skin, the margin of the
wounds was marked by significant acanthosis of epidermal
keratinocytes (Figure 2a). The area containing the acanthosis
of epidermal keratinocytes is magnified, showing that
keratinocyte growth in that layer is much more extensive in
the wounds from the MK2 WT mice compared with those
from the MK2 KO mice. There is a significantly higher level of
inflammatory cell infiltration in the wounded skin compared
with that in the unwounded skin, but there seems to be a
similar level of inflammatory cell infiltration in the wounds
from both the strains.
To illustrate the difference in wound size between the MK2
WT and MK2 KO mice, the largest diameter of the wounds on
histology slide sections was measured from day 4 wounds,
using a calibrated micrometer, by an observer blinded to the
strain identity of the slides. Using this approach, we found a
statistically significant difference (Figure 2b, Po0.001) in the
largest diameter of wounds from MK2 WT (3.42±0.46mm)
compared with that from MK2 KO mice (8.57±0.87mm)
(mean±SEM). To illustrate the difference in the wound
diameter, the edge of the growing keratinocyte layer is marked
with a vertical bar and an arrow in Figure 2a.
Higher rate of angiogenesis and collagen deposition in the
wounds of MK2 WT mice
The process of wound healing includes both deposition of
new collagen and angiogenesis (Somanath et al., 2008;
Tomita et al., 2009). To examine the rate of angiogenesis in
the wounds, immunohistochemistry analysis for Factor VIII
antigen was carried out. The wounds of MK2 WT had higher
levels of new blood vessels both in the granulation tissue and
the wound margins (Figure 3a, c and b, d, respectively).
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Figure 1. Delay in cutaneous wound healing in MK2 KO mice.
(a) Representative wounds are shown to illustrate the macroscopic differences
observed in the kinetics of wound healing between the MK2 wild-type
(WT) and MK2 knockout (KO) mice (b) Wound areas measured in MK2
WT (’) and MK2 KO ( ) mice are plotted for time points post wounding.
The ruler was included in each photograph to show the relative size of the
wounds. Macroscopically, the wounds of the MK2 WT mice (top) healed
faster than wounds of the MK2 KO mice. Results are mean±SEM, n¼ 16,
for each time point and group, **Pp0.010, ***Po0.001 compared toWTmice.
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To examine collagen deposition in the wounds, the
harvested wounds were stained with Masson trichrome. At
the wound edge, characterized by the acanthotic keratino-
cyte layer, new and old collagen can be seen. The old
collagen stains dark blue, away from the wound margin in
both strains of mice (open arrow). The newly formed collagen
at the edge of the wound is below the acanthotic keratinocyte
layer (closed arrow). The wounds in the MK2 KO mice
contain lower levels of new collagen, both on day 3 and
day 6, compared with the MK2 WT wounds (Figure 4a and b,
respectively). To quantitatively assess collagen deposition,
type 3 collagen (Col3a1) and type 1 collagen (Col1a1) mRNA
expression was analyzed by qPCR using RNA extracted from
wounds of both MK2 WT and null mice from day 0 to day 6
post wounding. A significantly higher level of Col3a1 was
expressed on days 2 and 3, whereas the expression of Col1a1
was significantly higher on days 3, 5, and 6 in the wounds of
MK2 WT compared with that in the wounds of MK2 KO mice
(Figure 4b and c, respectively; Po0.03).
Overall, wound healing is impaired both macroscopically
and microscopically in MK2-KO mice compared with that in
their MK2 WT counterparts. This slower healing is also charac-
terized by decreased collagen deposition in the MK2 KO mice.
Neutrophil and macrophage recruitment to the wound is
independent of MK2
Inflammatory cells play a central role in normal wound
healing. Immediately after injury, neutrophils are recruited to
the wound site and remain the major inflammatory cell type
during the early stages of wound healing. In the absence of
persistent infection, the neutrophils undergo apoptosis and
are cleared by the macrophages recruited at the later stages of
wound healing. Several studies have shown that impairment
in inflammatory cell recruitment to the wound site severely
affects the rate of wound healing (Low et al., 2001; Martin
et al., 2003; Martin and Leibovich, 2005; Peters et al., 2005;
Maruyama et al., 2007). To assess the role of MK2 in inflam-
matory cell recruitment to the wounds, the wound tissues from
day 1 to day 5 were subjected to immunofluorescent staining
using antibodies specific either to neutrophils (7/4) or to
macrophages (F4/80). As shown in Figure 5a and b, there were
no significant differences in the total number of macrophages
and neutrophils infiltrating either at the peak of neutrophil
infiltration (day 1) or at the peak of macrophage infiltration
(day 4) or any other day tested (days 2, 3, and 5; data not
shown) Thus, macrophage and neutrophil recruitment during
cutaneous wound healing is independent of MK2.
Cytokine analysis of the healing wounds
Wound healing is a complex biological process that is regu-
lated by numerous growth factors, cytokines and chemo-
kines. MK2 is a major regulator of cytokine and chemokine
expression. Although we established that the recruitment of
inflammatory cells to the wound site is independent of MK2,
these cells, along with other resident cells at the wound site,
may require MK2 to produce cytokines and chemokines that
are important for the regulation of wound healing, in addition
to other regulatory proteins. To determine the levels of
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Figure 2. Histological analysis of wound healing. Hematoxylin and Eosin
staining of the wound was carried out to observe the architecture and relative
size of the wounds at 4 days post wounding. (a) Microscopic representation of
the longest diameter of the wounds, where the arrows indicate the wound
margins. Magnified views of the wound margins show a greater degree of
acanthosis in wounds from MK2 wild-type (WT) mice, compared with that
in the MK2 knockout (KO) mice. (b) A calibrated micrometer was used to
measure the diameter of the wounds. Wound diameter was calculated
by blinded observers and results are mean±SEM, n¼ 4 for each strain of
mice. ***Po0.001, statistical analysis was carried out using Student’s
t-test. Bar¼1mm.
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Figure 3. Histological assessment of angiogenesis. At day 4 post wounding
skin sections from MK2 wild-type (WT) (a, c) and knockout (KO) (b, d)
mice were subjected to immunohistochemical staining with anti-Factor VIII
antibody. Newly forming blood vessels in the growing wound margins
(a, b) and in the granulation tissue (c, d) are marked with a closed arrow.
Original magnification  200, Bar¼ 25 mm.
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cytokines and chemokines being produced at the wound
site, wounds were harvested 1, 2, 3, 4, 5, and 6 days after
wounding, homogenized, and analyzed using Lincoplex
mouse cytokine kit (LincoResearch, St-Charles, MO). The
basal levels of cytokine and chemokine production were
established by analyzing unwounded skin from both the
strains of mice (0 days time point). We selected the following
cytokines, growth factors, and chemokines for analysis:
GM-CSF, vascular endothelial growth factor, IFNg, monocyte
chemotactic protein-1, IL-6, regulated on activation normal
T cell expressed and secreted, TNF, and IL-1b.
All of the tested proteins were expressed at higher levels in
the wounded skin than in unwounded controls from both
MK2 WT and MK2 KO mice. GM-CSF, vascular endothelial
growth factor, IFNg, and MCP1 protein levels were expressed
at significantly higher levels in day 1 wounds from WT mice
than in MK2 KO mice (Po0.05, Figure 6a–d). IL-6 and
regulated on activation normal T cell expressed and secreted
levels were significantly higher in WT mice than in MK2 KO
on day 3 and day 5, respectively (Po0.05, Figure 6e and f).
TNF and IL-1b levels were significantly different on multiple
days post wounding. TNF protein production was signifi-
cantly lower on day 1 and day 4 in MK2 null mice compared
with that in the WT mice (Po0.05, Figure 6g), whereas IL-1b
expression was lower in the WT mice on days 4, 5, and 6 post
wounding compared with that in mice lacking MK2.
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Figure 4. Histological assessment and mRNA analysis of collagen in the
healing wounds. At day 3 and 6 post wounding, wounds from MK2 knockout
(KO) and MK2 wild-type (WT) mice were stained for collagen with
Masson Trichrome. (a) Skin further from the wound margins in MK2 WT and
MK2 KO mice showed intense collagen staining, marked with the open
arrows. The newly formed collagen beneath the growing keratinocyte layer
is marked with closed arrows. Real-time PCR analysis of the expression
of the type 3 Collagen (Col3a1) (b) and the type 1 Collagen (Col1a1) (c) genes
in the wounds of MK2 WT mice (’) and KO mice ( ). All data are expressed
as mean±SEM (n¼4). Statistical analysis was carried out using a rank-sum
test (*Po0.03). Original magnification  100, Bar¼ 50 mm.
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Figure 5. Macrophage and neutrophil infiltration of the wounds.
(a) Immunofluorescent staining with antibodies against neutrophil marker
7/4 and macrophage-specific marker F4/80 on frozen OCT-compound
embedded wounds from day 1 and day 4 wounds, respectively. (b) 7/4þ
neutrophils and F4/80þ macrophages within the dermis of the wound margin
were counted in four high-powered fields (HPF) at 40 under a fluorescent
microscope. Results are mean±SEM, n¼4 for each strain of mice.
Statistical analysis was carried out using the Student’s t-test. No
statistically significant differences were found between the analyzed
specimens from MK2 knockout (KO) and MK2 wild-type (WT) mice.
PMN, polymorphonuclear leukocytes; OCT, optimal cutting temperature.
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Overall, these results show significantly higher expression
of several cytokines and chemokines in the healing wounds
of MK2 WT animals compared with that in the MK2 KO
mice. These findings suggest that MK2 signaling represents an
important biochemical pathway that controls the ability of
wound infiltrating inflammatory cells to produce cytokines
and chemokines.
Cutaneous wound healing is under the control of
MK2-dependent macrophage function
Many cell types, including keratinocytes, Langerhans cells,
fibroblasts, neutrophils, and macrophages influence the rate
of wound healing. We have previously shown that the
production of inflammatory cytokines by macrophages in
response to bacterial and viral products is dependent on MK2
(Thuraisingam et al., 2007). Furthermore, we and others have
clearly shown that macrophages play a critical role during
wound healing (Newton et al., 2004; Peters et al., 2005;
Thuraisingam et al., 2006; Maruyama et al., 2007). Pre-
viously, Danon et al. (1989) have shown that local injection
of macrophages can influence the rate of cutaneous wound
healing. Thus, to determine whether wound macrophages in
MK2 KO mice are significantly impaired in their function,
peritoneal macrophages from MK2 WT mice were passively
transferred intradermally to MK2 KO mice before excisional
wounding. Equal volumes of phosphate-buffered saline (PBS)
or peritoneal macrophages from MK2 KO mice were also
injected intradermally as controls. To evaluate the fate of the
injected cells, macrophages were labeled with PKH26 before
injection. Immunofluorescent analysis of wounds injected
with PKH26-labeled macrophages show survival of macro-
phages up to 72 hours post injection (Figure 7b). The wounds
*
*
*
*
*
*
*
*
*
*
*
12
10
8
6
4
2
0
120
80
40
0
250
200
150
100
50
0
12
8
4
0
40
30
20
10
0
lL
-1
be
ta
 (p
g m
l–1
)
R
AN
TE
S 
(pg
 m
l–1
)
M
CP
-1
 (p
g m
l–1
)
VE
G
F 
(pg
 m
l–1
)
0.8
0.6
0.4
0.2
0
TN
F 
(pg
 m
l–1
)
lL
-6
 (p
g m
l–1
)
lF
N
 g
am
m
a 
(pg
 m
l–1
)
G
M
-C
SF
 (p
g m
l–1
)
0
100
40
20
80
60
600
0
400
200
0 1 2 3 4 5 6 0 1 2 3 4 5 6
0 1 2 3 4 5 6
0 1 2 3 4 5 6
0 1 2 3 4 5 60 1 2 3 4 5 6
0 1 2 3 4 5 6
0 1 2 3 4 5 6
Figure 6. MK2-dependent cytokine induction during the course of wound
healing. The basal levels of cytokine and chemokine production were
established by analyzing unwounded skin from both strains of mice at
day 0. Wounds were harvested on days 1, 2, 3, 4, 5, and 6 post wounding,
as indicated. Wounds were excised with a clear margin, homogenized, and
subjected to cytokine and chemokine analysis using Beadlyte technology
(a) GM-CSF, (b) VEGF, (c) IFNg, (d) MCP-1, (e) IL-6, (f) RANTES, (g) TNF,
(h) IL-1. Results are mean±SEM, n¼ 4 for each strain of mice. Statistical
analysis was carried out using a rank-sum test. *Po0.05, comparing the
cytokine levels from wounds of MK2 knockout (KO) and MK2 wild-type (WT)
mice. WT mice (’) and KO mice ( ). MCP-1, monocyte chemotactic protein-
1; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor.
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Figure 7. Passive transfer of MK2 WT macrophages. Macrophages were
isolated from peritoneal exudate cells (PEC) from MK2 wild-type (WT) and
MK2 knockout (KO) mice, and were injected into KO mice intradermally
1 hour before excisional wounding. Sterile PBS was injected into a group of
KO mice as a control. To evaluate the fate of the injected cells, macrophages
were labeled with PKH26 before injection (a) Representative kinetics of
wound healing show quicker healing in the mice injected with PEC from
WT mice versus the other two groups. (b) Immunofluorescent analysis of
wounds injected with PKH26 labelled macrophages show survival of
macrophages up to 72 hours post-injection. *Scale bar¼ **50 mm. (c) Wound
areas measured in mice injected with PEC fromWT mice (’) or KO mice ( ).
PBS (&) injections were used as controls. The ruler (illustrating the distance
of 1mm) is included in each photograph to show the relative size of the
wounds. Results are mean±SEM, n¼8 for each group. **Pp0.032,
***Po0.001 compared with KO PEC-injected wound size.
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were monitored for 5 days post wounding. There was no
significant difference in the wound size amongst the three
groups immediately after the wounding. The wound size of
MK2 KO mice pre-injected with macrophages from WT mice
was significantly smaller as early as day 2 post wounding
compared with wounds pre-injected with either PBS or
macrophages from MK2 KO mice (P¼0.032, Figure 7c). The
difference remained significant compared with both control
groups until day 5, the last day on which the wounds were
monitored (Po0.024, Figure 7c). Throughout the entire
period during which the wounds were monitored, the PBS
control and the MK2 KO macrophage-injected wounds
remained approximately of the same size, with no statistically
significant difference observed between them. Macrophages
have already been established as key players during
cutaneous wound healing, and the results of this study show
that MK2 signaling is critical for the ability of macrophages
to promote wound healing and that transplantation of
MK2-competent macrophages into a wound area might be
considered as a possible therapy to improve the wound-
healing process.
DISCUSSION
An effective wound-healing process is critical to the survival
of the organism after injury. To investigate the possible role of
MK2 in this process, the kinetics of the healing process in
MK2 KO and WT mice were compared. MK2 KO mice are
significantly impaired in their ability to heal wounds after
injury as compared with that in their MK2 WT counterparts.
One possible mechanism to explain this deficiency could be
that MK2 KO mice were impaired in their ability to deposit
new collagen and to form new blood vessels at the wound
site. We have also shown that, although there is no difference
in the number or type of inflammatory cells recruited to the
wound site, MK2 KO mice are deficient in the production of
several important cytokines and chemokines. To investigate
the role of MK2 in mediating the specific response of
macrophages, which are important producers of inflamma-
tory mediators, we injected MK2-competent macrophages
into the wound sites of MK2 KO mice. Mice that received
WT macrophages showed significantly improved wound-
healing kinetics compared with mice receiving MK2 KO
macrophages or PBS. We have therefore shown that MK2
expression by macrophages is an important factor facilitating
the wound-healing process.
A major finding of this study is that many cytokine and
chemokine levels are significantly reduced in the wounds of
MK2 KO mice. The reduced expression of certain cytokines
may be an indirect effect of MK2. TNF and IL-1 have been
called master cytokines because of their ability to influence
the production of other cytokines such as IL-6 as well as the
radical product nitric oxide (Gosselin and Rivest, 2007).
Thus, the lower levels of IL-1 and TNF in the wounds of MK2
KO mice may indeed be causing the observed decrease in
the production of other cytokines. Regardless of whether the
effect on cytokine production is direct or indirect, all of the
cytokines found to be affected in the absence of MK2 have
been previously implicated in the wound-healing process.
For example, it has been shown through the use of GM-CSF
KO mice and GM-CSF antagonist overexpressing transgenic
mice, that the lack of GM-CSF not only causes a delay in
wound healing, but also severely compromises the quality of
newly formed tissue (Mann et al., 2006; Fang et al., 2007).
Vascular endothelial growth factor, monocyte chemotactic
protein-1, and nitric oxide are known to promote angiogen-
esis in wounds, and this vascularization in the wound bed
area is important for the proper supply of nutrients and
oxygen to allow rapid growth of the skin (Leibovich et al.,
1994; Frank et al., 1995; Salcedo et al., 2000). IL-6 KO mice
display multiple defects during cutaneous wound healing
leading to a severe delay in the kinetics of healing (Lin et al.,
2003). Schaffer et al. (2006) have shown that wound breaking
strength and nitric oxide production are severely compro-
mised in the wounds of IFNg KO mice, and IFNg-induced
nitric oxide production in the wounds is directly linked to
TNF availability. TNF and IL-6 are also able to influence the
rate of wound healing through regulation of a smooth muscle
actin expression in dermal fibroblasts (Gallucci et al., 2006;
Goldberg et al., 2007).
Even on those days after wounding where cytokine levels
were not found to be significantly different between the
wounds of MK2WT and MK2 KO mice, the lack of MK2 gene
expression could still affect the healing properties of these
abundantly expressed cytokines. Kobayashi et al. (2006) have
shown that vascular endothelial growth factor-mediated actin
remodeling and cell migration is dependent on MK2
signaling. With the use of p38 MAPK inhibitor SB203580, it
has been shown that the activation of neutrophils by GM-CSF
and TNF is dependent on the p38 MAPK/MK2 signaling
pathway (ten Hove et al., 2007). Therefore, MK2 may
mediate the cytokines and chemokines in the wounds not
only at the level of production as we have shown in Figure 6,
but also at the level of their biological activity as promoters of
wound healing.
Although MK2 KO mice that were injected with macro-
phages from MK2 competent mice dramatically improved
their kinetics of healing, they did not show the same wound-
healing kinetics that we observed in the WT mice. This
observation suggests that other yet unidentified factors
affecting the rate of wound healing in the MK2 WT mice
might also be dependent on MK2 signaling. One possible
explanation is that the absence of MK2 signaling in other cell
types, such as keratinocytes, fibroblasts, Langerhans cells, or
neutrophils, slows the healing process. Deficiency in MK2
has also been linked to the impairment of actin remodeling in
fibroblasts (Liu et al., 2007), and fibroblasts could therefore
be playing an important role in delaying wound healing in
MK2 KO mice. Although we have shown that passive transfer
of MK2 competent macrophages improves the kinetics of
wound healing, the role of inflammatory cells during wound
healing is still debated. In the absence of inflammatory
stimuli, no significant differences in the pattern or amounts of
inflammatory cytokines can be found when cytokine
production has been assed using purified macrophages or
neutrophils isolated from MK2KO and MK2WT mice (data
not shown). As illustrated by the results of our studies, the
www.jidonline.org 283
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inflammatory response in the wound environment depends
on MK2.
Our study shows a correlation of the lack of inflammatory
response with delayed rate of wound healing in MK2KO
mice. It needs to be mentioned that inflammation has also
been shown to negatively affect the process of wound healing
(Ashcroft et al., 1999; Ghazizadeh, 2007; Wilgus et al.,
2008). In diabetic patients, exaggerated and prolonged
inflammatory reactions seem to be associated with impaired
wound healing (Acosta et al., 2008). Furthermore, Martin and
colleagues showed improved kinetics of wound healing in
PU.1 KO mice lacking macrophages and functioning
neutrophils (Martin et al., 2003; Cooper et al., 2005; Martin
and Leibovich, 2005). Certainly, further studies are warranted
to elucidate the exact role of specific subsets of inflammatory
cells and/or temporal levels of soluble mediators during the
process of wound repair using various models of wound
healing.
Overall, the results of this study show that the MK2
signaling pathway is critical during cutaneous wound healing.
The insight gained from this study allows us to consider
previously unreported diagnostic and therapeutic approaches
in wound-healing research. Chronic wounds resulting from
an impaired wound-healing process could be assessed for
their overall levels of MK2 gene expression and if found to be
compromised, the transplantation of MK2 competent macro-
phages from healthy histocompatibility antigen-matched
donors could be a helpful therapeutic approach.
MATERIALS AND METHODS
Mice
To generate MK2 KO mice, a neomycin cassette was inserted into
the exon that encodes subdomains V and VI of the MK2 gene of
129/J mice, as described previously (Kotlyarov et al., 1999). We have
backcrossed these mice to C57BL/6 mice for 22 generations. These
backcrossed MK2 KO mice were used for in vivo studies. Mice
were bred according to Animal Care Committee protocol in the
Montreal General Hospital Research Institute Animal Facility under
specific pathogen-free conditions. All experimental animal work
was approved by the Montreal General Hospital Animal Care
Committee.
Wound-healing model
In total, 8–10-week-old MK2 KO and MK2 WT female mice were
used for all in vivo experiments. The wounds were made as
previously described in detail (Thuraisingam et al., 2006). Wounded
mice were monitored daily and the wounds were measured with
sterile callipers. Wounds were considered fully healed when the
largest width of the wound measured less than or equal to 0.1mm
(lowest limit of accurate measurement by the calliper).
Quantitative real-time PCR
Total RNA extraction from wounds and real-time reverse transcrip-
tion-PCR for the type 1 collagen (Col1a1) and type 3 collagen
(Col3a1) genes was carried out as described previously (Thuraisingam
et al., 2006). Amplification of the GAPDH mRNA was used for
normalization of the results. The relative expression between the
samples was calculated based on the threshold cycle (CT) value.
Altered mRNA levels are expressed as fold changes relative to those
in KO control wounds. We also confirmed that a single product of
the expected length was amplified. Only primers with an efficiency
of 90% or higher were used. Primer sequences used are presented in
Supplementary Table S1 and all primers were synthesized by IDT
Technologies (Coralville, IA).
PKH26 labeling and passive cell transfer to the wounds
Peritoneal exudate cells were obtained by injecting 1.0ml of 4%
thioglycolate broth (Becton, Dickinson & Co, Sparks, MD) solution
intraperitoneally in 8–10-week-old female mice. After 4 days, the
peritoneal cavity was flushed using HBSS (Invitrogen, Burlington,
ON, Canada). Cells were spun down and red cells were lysed by
adding 10–15ml of ACK lysing buffer (Cambrex, East Rutherford, NJ)
and incubated for 3–5minutes on ice. To increase the purity of the
macrophage population, isolated cells were subjected to positive
selection by CD11b MACS beads (Miltenyi Biotech, Auburn, CA)
according to manufacturer’s protocol. Positively selected cells were
labeled with PKH26 fluorescence dye (Sigma-Aldrich, Oakville, ON,
Canada) according to the manufacturer’s instructions. Briefly, the
cells were washed with PBS, centrifuged, and 250ml of Diluent C
(Sigma-Aldrich) was subsequently added to the cell suspension.
Atotal of 15ml of the PKH dye was then added to 250ml of Diluent C.
After 6minutes incubation at room temperature, fresh culture
medium was added to stop further incorporation of the fluorescent
dye into the cell membranes. The cell suspension was washed and
centrifuged thrice. A 0.1ml suspension containing 0.5 106 labeled
or unlabeled cells or PBS alone was injected intradermally in
isofluorane-anesthetized mice 1 hour before wounding at the future
wound site (Danon et al., 1989).
Histology and direct immunofluorescence analysis
Wounded tissues were harvested, fixed in 10% buffered formalin,
dehydrated, bisected, mounted in paraffin, and sectioned for
histology and immunohistochemistry. Deparaffinized and hydrated
sections were stained using Hematoxylin and Eosin. Collagen was
stained with Masson trichrome. Immunohistochemistry was carried
out with antibodies specific for Factor VIII using rabbit anti-human
Factor VIII (1:500, DakoCytomation, Mississauga, ON, Canada).
Briefly, primary antibody-coated slides were incubated for
60minutes, followed by three 20-minute washes in TBS-0.05%
Tween 20, and then incubated with secondary antibody for
30minutes at room temperature. Slides were then incubated with
avidin–biotin–horseradish peroxidase complexes (ABC, Vector
Laboratories, Burlingame, CA) for 30minutes. Color was developed
with Fast Red chromogen (Sigma-Aldrich, Oakville, ON, Canada)
in Tris buffer, and the slides were counterstained with Harris
hematoxylin (EM Science, Gibbstown, NJ). All histology was
carried out on multiple sections from individual mice from three
independent in vivo wounding experiments.
For immunofluorescent staining, 4-day wounds were harvested,
bisected and immersed in 4% paraformaldehyde in 0.1M phosphate
buffer overnight, followed by cryoprotection overnight at 41C in 30%
sucrose 0.1M phosphate buffer. Serial cryostat sections (12mm) were
obtained from OCT compound embedded tissues (Sakura Finetek USA
Inc., Torrance, CA) and were washed thrice in PBS for 5minutes,
followed by 1hour blocking at room temperature with blocking
solution (10% normal goat serum, 10% normal donkey serum in PBS
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0.1% Tween 20 (Fisher, Fairlawn, NJ)). The sections were then
incubated overnight at room temperature with rat anti-mouse 7/4
(1:200; Serotech, Raleigh, NC) or rat anti-mouse F4/80 (5mgml1,
clone CI:A3-1; Serotech) in blocking solution. After washing in PBS,
sections were incubated with Alexa Fluor 594-conjugated donkey
anti-rat antibody (1:200, Molecular Probes, Eugene, OR) for 1hour
at room temperature. Slides were mounted with VECTASHIELD
hardest mounting media with DAPI (4’-6-Diamidino-2-phenylindole)
(Vector, Burlington, ON). Images were captured with a Retiga 1300 C
digital camera (QImaging Corp., Burnaby, BC, Canada), and all the
sections were analyzed with the BioQuant Nova Prime image analysis
system (BioQuant Image Analysis, Nashville, TN) using a Zeiss
AxioSkop II (Carl Zeiss Canada, Toronto, ON, Canada) microscope.
Cytokine and chemokine measurements
After killing of the animals, wounds were excised with a clear
margin and snap frozen in liquid nitrogen. Half of the wound from
each sample was then homogenized in 4ml of PBS containing a
protease inhibitor cocktail (Complete Inhibitor, Roche Diagnostics,
Laval, PQ, Canada) and the total protein concentrations were
adjusted using the Bio-Rad protein assay dye (Bio-Rad Laboratories,
Hercules, CA). The other half was kept frozen for RNA analysis.
Samples were concentrated 20-fold with Microcon YM-3 centrifugal
filters (Millipore, Billerica, MA) before analysis using a custom
Lincoplex mouse cytokine kit (Linco Research, St Charles, MO) on a
Luminex 100 LS apparatus with software version 2.3 (Luminex,
Austin, TX). The cytokine protein levels reported refer to the cytokine
levels of the samples in the skin homogenates as they were originally
prepared, and not the 20-fold concentrated homogenates as the
samples were assayed.
Statistical analysis
SigmaStat software (Systat, Point Richmond, CA) was used to
calculate statistical significance. For normally distributed data
groups, the Student’s t-test was used. Non-normally distributed
data was evaluated using a non-parametric rank-sum test. Potential
differences among various groups were considered significantly
different from the others for Po0.05.
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